AD is a progressive neurodegenerative disease, and one of the most important approaches in the multifunction therapy of AD is the inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE). The gene discussed is BCHE; the disease is Alzheimer disease.